Luxembourg declines to extend Israeli bond-prospectus approval arrangement

Luxembourg’s refusal to continue a temporary role in approving an Israeli sovereign-bond prospectus after 31 August should not be described as the rejection of an Irish application to list bonds on the Luxembourg Stock Exchange. It was neither. The verified legal process is an issuer-led request to transfer responsibility for approving one prospectus between national regulators; a stock-exchange listing is a separate matter.

That distinction is more than technical. A clarification attributed to the European Securities and Markets Authority by the Luxembourg Times has brought into focus the discretion of the receiving authority. Luxembourg’s financial supervisor, the CSSF, agreed to take the 2025 case from Ireland and approved the prospectus. It has now declined to extend the arrangement, according to the newspaper and RTL Today. The public record does not disclose its reasoned decision or the underlying correspondence.

A transfer is not a listing

Israel chose Ireland as its EU home member state for non-equity securities with denominations below €1,000 after Brexit. Under Article 20(8) of the EU Prospectus Regulation, an issuer, offeror or applicant for admission to trading may request that the home authority transfer approval of a particular prospectus to an authority in another member state. ESMA must be notified and the receiving authority must agree.

The wording matters. The regulation does not say that Ireland can unilaterally send a file elsewhere. Nor does it make the transfer an endorsement of the issuer or its financing. Once a transfer is completed, the receiving authority is deemed to be the home authority for that prospectus and carries out the scrutiny.

The Central Bank of Ireland says Israel requested the 2025 transfer and that the CSSF then independently reviewed and approved the prospectus. Ireland was not among the countries in which the 2025 prospectus offered bonds to the public; the listed jurisdictions were Austria, France, Germany, Luxembourg and the Netherlands. Luxembourg’s foreign ministry gave the same account in September 2025.

That record makes the phrase “Ireland’s application” imprecise. The request originates with the issuer under Article 20(8), even if it is handled through Ireland as home authority. It also makes “Luxembourg listing” misleading. LuxSE says that CSSF handles prospectus approval for the Bourse de Luxembourg market. CSSF, in turn, has delegated publication of approved prospectuses to the exchange. Publication, approval and admission to trading are connected processes, but they are not interchangeable.

What is known about the 2026 refusal

RTL reported that CSSF Director General Claude Marx said the decision not to extend authorisation after 31 August rested on European regulation rather than politics. He characterised the 2025 transfer as a limited, 12-month exception because Israel’s underlying choice of home country was final.

“not there to make rules. [It is] there to apply rules”

There is a genuine question here, but it is narrower than the political dispute surrounding Israel’s war in Gaza. Article 20(8) expressly permits transfer of approval for a particular prospectus and requires the recipient authority’s agreement. It does not, in its text, set a one-year ceiling. That does not establish that CSSF was obliged to accept a new transfer: a new prospectus would be a new request and the recipient’s agreement is a stated condition. It does mean that the legal rationale for the refusal should be set out with greater precision if public confidence is to be maintained.

The Central Bank of Ireland has taken the opposite practical position on its own obligations. Its published FAQ says that, where disclosure is complete, consistent and comprehensible, it must approve a prospectus. It gives inadequate disclosure, EU financial sanctions affecting the relevant services, or equivalent national measures as examples of grounds to refuse. In its 2025 response to parliament, it said it had found no basis in EU, Irish or international law to reject the transfer of approval.

Two different tests, one transparency problem

The contrast does not by itself prove a contradiction. Ireland’s assessment concerned its role as the transferring home authority; Luxembourg’s 2026 decision concerned whether to accept a further transfer. Confidentiality rules limit what the Irish central bank can reveal about exchanges with Israel and CSSF. Still, the absence of a public, reasoned account leaves a gap between the broad rule and its application.

• Was the CSSF’s refusal based on the one-prospectus nature of Article 20(8), on the regulatory connection to Luxembourg, or on another legal consideration?
• What exactly did ESMA clarify about a receiving authority’s discretion, and was that view communicated to both regulators?
• Would a new Israeli prospectus return automatically to Ireland, or could its approval be transferred again if another authority agreed?

Those questions are consequential for Luxembourg beyond this issuer. LuxSE presents itself as a leading international debt-securities venue, and its 2025 results show the scale of that business. The issue is not evidence that the refusal has damaged the market; no such effect is publicly established. It is whether issuers, investors and political critics can see how a nationally applied EU rule produces a decision.

The credibility test for Luxembourg

Marx has acknowledged that the episode may have hurt Luxembourg’s reputation because of how it was presented. The more durable risk is a different one: if a financial centre is seen as mechanically applying rules in one politically charged case and as relying on unarticulated discretion in the next, confidence in regulatory predictability suffers.

Luxembourg can avoid that outcome without converting a prospectus review into a foreign-policy judgment. CSSF could explain the legal basis and procedural limits of its 2026 decision while preserving protected information. Ireland could clarify the route available when a particular transferred prospectus expires. And ESMA could publish general guidance on repeat transfer requests. For a capital-markets centre built on cross-border issuance, clarity is not a cosmetic extra. It is part of the product.